This inventor holds 1 USPTO granted patent. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 17 
1 out of 264 
Years Active: 2022
Title: Innovation in Cancer Treatment: The Contributions of Hye-Young Park
Introduction: Hye-Young Park, an inventor based in Yongin-si, South Korea, has made significant strides in the field of biomedical research. With a focus on cancer treatment, Park's work on anti-CEACAM1 antibodies has the potential to revolutionize therapeutic approaches for various cancers. This article delves into his latest patents, career highlights, and collaborative efforts.
Latest Patents: Hye-Young Park holds a patent for an "Anti-CEACAM1 antibody and use thereof." This innovative invention provides anti-CEACAM1 antibodies with enhanced binding abilities specific to CEACAM1. The antibodies not only exhibit superior binding capabilities but also activate the anti-cancer immune functions of cytotoxic T cells and natural killer cells. As a result, these antibodies can serve as effective anti-cancer agents and compositions for treating cancer.
Career Highlights: Hye-Young Park has held notable positions in reputable organizations, including the Mogam Institute for Biomedical Research and the Green Cross Corporation. His work in these institutions has facilitated advancements in cancer research and therapy, underscoring his commitment to improving patient outcomes.
Collaborations: Throughout his career, Park has collaborated with accomplished professionals in the field, including So-Young Eun and Miyoung Oh. These partnerships have contributed to the refinement and application of his innovative inventions, highlighting the importance of teamwork in the pursuit of scientific advancements.
Conclusion: Hye-Young Park's contributions to the development of anti-CEACAM1 antibodies reflect a significant advancement in the fight against cancer. Through his innovative approach and collaborative efforts, Park continues to pave the way for future breakthroughs in cancer research and treatment. His work exemplifies the critical role of inventors in transforming scientific ideas into practical applications that can benefit society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile